1260EGP
- Active ingredient
- insulin aspart
- Strength
- 100i.u./ml
- Form
- pen
- Manufacturer
- novo nordisk > united company for trading & distribution
- Route
- injection
Uses
Rapid-acting insulin analogue used to improve glycemic control in patients with diabetes mellitus.
Do not use if
Episodes of hypoglycemia and hypersensitivity to insulin aspart or formulation components.
Side effects
Hypoglycemia is the most common adverse effect. Other effects include injection-site reactions and hypokalemia.
Warnings
Monitor blood glucose closely. Changes in insulin regimen require careful medical supervision.
How it works
Promotes glucose uptake into tissues and suppresses hepatic glucose production, lowering blood glucose levels.
Storage
Store refrigerated before use. Follow product-specific storage instructions after opening.
